haloperidol has been researched along with eticlopride in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.00) | 18.7374 |
| 1990's | 12 (48.00) | 18.2507 |
| 2000's | 6 (24.00) | 29.6817 |
| 2010's | 6 (24.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bengtsson, S; de Paulis, T; Hall, H; Högberg, T; Johansson, L; Ogren, SO; Ström, P | 1 |
| Angeby-Möller, K; de Paulis, T; Hall, H; Johansson, L; Kumar, Y; Ogren, SO; Rämsby, S; Sällemark, M | 1 |
| Demattos, S; MacKenzie, RG; O'Malley, KL; Pugsley, TA; Shih, YH; Tang, L; Todd, RD; VanLeeuwen, D | 1 |
| Fang, X; Hu, Z; Levant, B; Min, J; Varady, J; Wang, S; Wu, X | 1 |
| Hoffman, DC | 1 |
| Batsche, K; Granoff, MI; Wang, RY | 1 |
| Zahm, DS | 1 |
| Jenner, P; Jolkkonen, J; Marsden, CD | 1 |
| Bernard, A; Cavegn, C; Chabert, C; Mills, A | 1 |
| Nantwi, KD; Schoener, EP | 1 |
| Efange, SM; Khare, AB; Langason, RB | 1 |
| Burris, KD; Fausing, SM; Molinoff, PB | 1 |
| Dalia, A; Uretsky, NJ; Wallace, LJ | 1 |
| Fowler, SC; Liou, JR | 1 |
| Bonci, A; Malenka, RC; Thomas, MJ | 1 |
| Borgkvist, A; Fisone, G; Greengard, P; Håkansson, K; Lindskog, M; Pozzi, L; Usiello, A | 1 |
| Meredith, GE; Napier, TC; Switzer, RC | 1 |
| Bennett, S; Gronier, B | 1 |
| Bezzina, G; Body, S; Bradshaw, CM; Cheung, TH; Fone, KC; Hampson, CL; Szabadi, E | 1 |
| Arai, Y; Kikuchi, T; Mitazaki, S; Nakagawasai, O; Nakaya, K; Niijima, F; Onogi, H; Sato, A; Tadano, T; Tan-No, K | 1 |
| Ballion, B; Benoit-Marand, M; Boraud, T; Borrelli, E; Gonon, F | 1 |
| Al-Azzawi, H; Clayton, RN; Farrell, WE; Hofland, LJ; Richardson, A; Yacqub-Usman, K | 1 |
| Bezerra, EM; Caetano, EW; da Costa, RF; Freire, VN; Gottfried, C; Martins, A; Nunes, G; Zanatta, G | 1 |
| Mao, LM; Wang, JQ | 1 |
| Cao, T; Chen, J; Jiang, Y; Waddington, JL; Wang, C; Wang, P; Zhen, X | 1 |
25 other study(ies) available for haloperidol and eticlopride
| Article | Year |
|---|---|
Potential antipsychotic agents 5. Synthesis and antidopaminergic properties of substituted 5,6-dimethoxysalicylamides and related compounds.
Topics: Animals; Antipsychotic Agents; Apomorphine; Binding Sites; Chemical Phenomena; Chemistry; Dopamine Antagonists; Male; Raclopride; Rats; Rats, Inbred Strains; Salicylamides; Spiperone; Structure-Activity Relationship | 1990 |
Potential neuroleptic agents. 4. Chemistry, behavioral pharmacology, and inhibition of [3H]spiperone binding of 3,5-disubstituted N-[(1-ethyl-2-pyrrolidinyl)methyl]-6-methoxysalicylamides.
Topics: Animals; Apomorphine; Chemical Phenomena; Chemistry; Corpus Striatum; Haloperidol; Male; Raclopride; Rats; Rats, Inbred Strains; Receptors, Dopamine; Salicylamides; Spiperone; Stereotyped Behavior; Structure-Activity Relationship | 1986 |
Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
Topics: Animals; Arachidonic Acid; Binding, Competitive; Cell Line; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Cyclic AMP; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Humans; Inositol Phosphates; Mice; Radioligand Assay; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3; Tetrahydronaphthalenes; Transfection | 1994 |
Molecular modeling of the three-dimensional structure of dopamine 3 (D3) subtype receptor: discovery of novel and potent D3 ligands through a hybrid pharmacophore- and structure-based database searching approach.
Topics: Algorithms; Binding Sites; Computational Biology; Crystallography, X-Ray; Databases, Protein; Humans; Kinetics; Ligands; Lipid Bilayers; Models, Molecular; Molecular Conformation; Mutation; Receptors, Dopamine D2; Receptors, Dopamine D3; Reproducibility of Results; Solvents; Structure-Activity Relationship; Tetrahydronaphthalenes; Water | 2003 |
Typical and atypical neuroleptics antagonize MK-801-induced locomotion and stereotypy in rats.
Topics: Animals; Antipsychotic Agents; Clozapine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Haloperidol; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Salicylamides; Stereotyped Behavior | 1992 |
5-HT3 receptor antagonists fail to block the suppressant effect of cocaine on the firing rate of A10 dopamine neurons in the rat.
Topics: Animals; Cocaine; Dopamine; Electrophysiology; Haloperidol; Male; Neurons; Rats; Rats, Sprague-Dawley; Salicylamides; Serotonin Antagonists | 1992 |
Subsets of neurotensin-immunoreactive neurons revealed following antagonism of the dopamine-mediated suppression of neurotensin immunoreactivity in the rat striatum.
Topics: Animals; Benzazepines; Calbindins; Caudate Nucleus; Corpus Striatum; Dopamine; Dopamine Antagonists; Haloperidol; Immunohistochemistry; Male; Neurons; Neurotensin; Oxidopamine; Putamen; Rats; Rats, Inbred Strains; S100 Calcium Binding Protein G; Salicylamides | 1992 |
GABAergic modulation of striatal peptide expression in rats and the alterations induced by dopamine antagonist treatment.
Topics: Animals; Baclofen; Benzazepines; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Enkephalins; gamma-Aminobutyric Acid; Gene Expression Regulation; Glutamate Decarboxylase; Haloperidol; In Situ Hybridization; Male; Muscimol; Protein Precursors; Rats; Rats, Wistar; Receptors, GABA; RNA, Messenger; Salicylamides; Substance P; Tachykinins; Vigabatrin | 1994 |
Characterization of the functional activity of dopamine ligands at human recombinant dopamine D4 receptors.
Topics: Animals; Cell Line; Clozapine; DNA; Dopamine; Dopamine Agents; Ergolines; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Humans; Ligands; Moths; Quinpirole; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D4; Recombinant Proteins; Salicylamides; Spiperone; Sulfur Radioisotopes; Tritium | 1994 |
Cocaine and dopaminergic actions in rat neostriatum.
Topics: Animals; Benzazepines; Cocaine; Depression, Chemical; Dopamine; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Electrophysiology; Haloperidol; Infusions, Intravenous; Levodopa; Male; Neostriatum; Neurons; Procaine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides | 1993 |
Age-related diminution of dopamine antagonist-stimulated vesamicol receptor binding.
Topics: Aging; Animals; Brain; Dopamine Antagonists; Haloperidol; Iodine Radioisotopes; Iodobenzenes; Male; Piperidines; Radionuclide Imaging; Rats; Rats, Inbred F344; Rats, Wistar; Receptors, Cholinergic; Salicylamides; Time Factors | 1996 |
Regulation of D2 and D3 receptors in transfected cells by agonists and antagonists.
Topics: Adenylyl Cyclase Inhibitors; Brain; Cell Line; Dopamine Agonists; Dopamine Antagonists; GTP-Binding Proteins; Haloperidol; Humans; Kinetics; Receptors, Dopamine D2; Receptors, Dopamine D3; Recombinant Proteins; Salicylamides; Sulpiride; Transfection; Up-Regulation; Virulence Factors, Bordetella | 1998 |
Dopaminergic agonists administered into the nucleus accumbens: effects on extracellular glutamate and on locomotor activity.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Caffeine; Central Nervous System Stimulants; Dopamine Agonists; Dopamine Antagonists; Glutamic Acid; Haloperidol; Male; Motor Activity; Nucleus Accumbens; Quinpirole; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |
Haloperidol, raclopride, and eticlopride induce microcatalepsy during operant performance in rats, but clozapine and SCH 23390 do not.
Topics: Animals; Antipsychotic Agents; Benzazepines; Catalepsy; Clozapine; Conditioning, Operant; Haloperidol; Male; Raclopride; Rats; Rats, Sprague-Dawley; Salicylamides | 1998 |
Modulation of long-term depression by dopamine in the mesolimbic system.
Topics: Animals; Benzazepines; Conditioning, Psychological; Dopamine; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Limbic System; Long-Term Potentiation; Mesencephalon; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Neural Inhibition; Neuronal Plasticity; Neurons; Nucleus Accumbens; Patch-Clamp Techniques; Quinpirole; Salicylamides; Substance-Related Disorders; Sulpiride; Ventral Tegmental Area | 2000 |
Opposite regulation by typical and atypical anti-psychotics of ERK1/2, CREB and Elk-1 phosphorylation in mouse dorsal striatum.
Topics: Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Cyclic AMP Response Element-Binding Protein; DNA-Binding Proteins; Dopamine and cAMP-Regulated Phosphoprotein 32; Dopamine Antagonists; Drug Interactions; ets-Domain Protein Elk-1; Haloperidol; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins; Salicylamides; Transcription Factors | 2003 |
Short-term, D2 receptor blockade induces synaptic degeneration, reduces levels of tyrosine hydroxylase and brain-derived neurotrophic factor, and enhances D2-mediated firing in the ventral pallidum.
Topics: Animals; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Cell Survival; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Administration Schedule; Dyskinesia, Drug-Induced; Haloperidol; Immunohistochemistry; Male; Microscopy, Electron; Nerve Degeneration; Presynaptic Terminals; Prosencephalon; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Salicylamides; Synaptic Transmission; Tyrosine 3-Monooxygenase | 2004 |
Modulation of striatal dopamine release in vitro by agonists of the glycineB site of NMDA receptors; interaction with antipsychotics.
Topics: Animals; Antipsychotic Agents; Clozapine; Corpus Striatum; Dizocilpine Maleate; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Synergism; Glycine; Haloperidol; Magnesium; Male; N-Methylaspartate; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Glycine; Receptors, N-Methyl-D-Aspartate; Salicylamides | 2005 |
Effect of quinpirole on timing behaviour in the free-operant psychophysical procedure: evidence for the involvement of D2 dopamine receptors.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Female; Haloperidol; Quinpirole; Rats; Rats, Wistar; Reaction Time; Salicylamides; Sulpiride | 2007 |
p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.
Topics: Animals; Benzazepines; Clozapine; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Haloperidol; Indoles; Injections, Intraventricular; Male; Mice; Mice, Inbred Strains; Oxidopamine; p-Hydroxyamphetamine; Piperazines; Piperidines; Pyridines; Pyrroles; Reflex, Startle; Salicylamides; Sensory Gating; Sympathomimetics; Synaptic Transmission | 2010 |
Inhibition of dopamine uptake by D2 antagonists: an in vivo study.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Electric Stimulation; Haloperidol; Medial Forebrain Bundle; Mice; Mice, 129 Strain; Mice, Inbred C57BL; Mice, Knockout; Neural Pathways; Nomifensine; Presynaptic Terminals; Receptors, Dopamine D2; Salicylamides; Synaptic Transmission; Ventral Tegmental Area | 2011 |
Reversal of endogenous dopamine receptor silencing in pituitary cells augments receptor-mediated apoptosis.
Topics: Animals; Apoptosis; Bromocriptine; Cell Line; Chromatin Immunoprecipitation; DNA Methylation; Dopamine Agonists; Dopamine Antagonists; Haloperidol; Histones; Pituitary Gland; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Salicylamides | 2011 |
Antipsychotic haloperidol binding to the human dopamine D3 receptor: beyond docking through QM/MM refinement toward the design of improved schizophrenia medicines.
Topics: Antipsychotic Agents; Dopamine Antagonists; Haloperidol; Humans; Models, Chemical; Molecular Docking Simulation; Quantum Theory; Receptors, Dopamine D3; Salicylamides; Schizophrenia; Static Electricity | 2014 |
Antagonism of Dopamine D2 Receptors Alters Phosphorylation of Fyn in the Rat Medial Prefrontal Cortex.
Topics: Animals; Dopamine Antagonists; Haloperidol; Hippocampus; Male; Phosphorylation; Prefrontal Cortex; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-fyn; Rats; Rats, Wistar; Receptors, Dopamine D2; Salicylamides | 2017 |
D2 receptor-mediated miRNA-143 expression is associated with the effects of antipsychotic drugs on phencyclidine-induced schizophrenia-related locomotor hyperactivity and with Neuregulin-1 expression in mice.
Topics: Animals; Benzazepines; Clozapine; Dopamine D2 Receptor Antagonists; Haloperidol; Hippocampus; Male; Mice; Mice, Transgenic; MicroRNAs; Motor Activity; Neuregulin-1; Phencyclidine; Prefrontal Cortex; Primary Cell Culture; Quinpirole; Receptors, Dopamine D2; Salicylamides | 2019 |